Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Petros Pharmaceuticals Inc (NQ: PTPI )

2.540 -0.060 (-2.31%)
Streaming Delayed Price Updated: 12:46 PM EST, Feb 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,473
Open 2.510
Bid (Size) 2.450 (7)
Ask (Size) 2.560 (1)
Prev. Close 2.600
Today's Range 2.450 - 2.630
52wk Range 1.910 - 28.80
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Stocks That Hit 52-Week Lows On Thursday
  During Thursday's trading, 138 companies set new 52-week lows. 
Via Benzinga
Petros Pharmaceuticals Announces Reverse Stock Split
Via ACCESSWIRE

Performance

YTD
-20.38%
-20.38%
1 Month
-20.38%
-20.38%
3 Month
-48.16%
-48.16%
6 Month
-66.80%
-66.80%
1 Year
-85.32%
-85.32%

More News

Read More
Petros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Corporate Update
Via ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Why Pinterest Shares Are Trading Higher; Here Are 27 Stocks Moving Premarket
Via Benzinga
New FDA-Approved Labeling for Petros Pharmaceuticals’ STENDRA (avanafil) Now Includes Efficacy Data Regarding Use in Men Who Have Undergone Radical Prostatectomy
Via ACCESSWIRE
Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday
Via Benzinga
Petros Pharmaceuticals to Participate in Two October 2022 Conferences
Via ACCESSWIRE
Why Crown Holdings Shares Are Trading Lower By Around 22%? Here Are 46 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Internationally Published, Head-to-Head Data From India of Petros Pharmaceuticals' STENDRA(R) (Avanafil) Tablets Reported Improvement in Erectile Function Compared to Sildenafil and Baseline After 12 Weeks of Therapy
Via ACCESSWIRE
Petros Pharmaceuticals Reports Record Revenue and Gross Profit During Second Quarter 2022
Via ACCESSWIRE
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
Via Benzinga
Why Shares Of Oil & Gas Companies Are Trading Lower, Here Are 62 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Short Volatility Alert: Petros Pharmaceuticals, Inc.
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
What Is Going on With Petros Pharmaceuticals (PTPI) Stock Today?
Via InvestorPlace
Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
InflaRx Climbs More Than 40%, Here's 58 Biggest Movers From Yesterday
Via Benzinga
Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
88 Biggest Movers From Yesterday
Via Benzinga
28 Stocks Moving in Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
54 Biggest Movers From Yesterday
Via Benzinga
64 Biggest Movers From Friday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.